TissueGene, Inc. Report issue

For profit Phase 2 Phase 3
Founded: Rockville MD United States (1999)

Organization Overview

First Clinical Trial
2007
NCT00599248
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kolon Life Science | TissueGene, Inc.